CLDI.WS

Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CLDI.WS was delisted on the 17th of October, 2024.

Back to rankings

15 hedge funds and large institutions have $99.4K invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.3K
2
+$64
3
+$19
4
Citadel Advisors
Citadel Advisors
Florida
+$3

Top Sellers

1
-$68.1K
2
-$1.56K
3
-$205
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$30.2K
2
$20.7K
3
$9.3K
4
$8.58K
5
$7.86K
6
$6.9K
7
$6.08K
8
$4.33K
9
$2.25K
10
$1.38K
11
$926
12
$478
13
$263
14
$87
15
$70
16
–